RecallDepth
Class II Terminated

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

This recall has been terminated (originally issued June 5, 2013).

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
April 22, 2013
Posted
June 5, 2013
Recall Number
D-500-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,048 bottles
Firm Location
Morgantown, WV, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..

Distribution

Nationwide

Lot / Code Info

Lot # ZRMB11004, Exp 09/13

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls